Vitamin D Testing Market Size, Status and Forecast to 2027

Growing Adoption of 25-Hydroxy D Vitamin Test as a Less-invasive Option

Vitamin D deficiency is a common problem faced by many people all around the world, particularly older adults. Since vitamin D plays an important role in the development and calcification of the bones, a lot of individuals are seeking easy and safer ways of testing their vitamin D levels.

Stakeholders in the vitamin D testing landscape are evaluating the use of HPLC (High Performance Liquid Chromatography) to assess the analytical performance of the 25-hydroxy D vitamin test in human serum. This has been validated with the help of the electrochemiluminescence (ECL) method. Results showed that, HPLC assay indicates exceptional linearity with admissible accuracy to measure vitamin D using the ECL method. Also, the relatively short analysis time makes it a lucrative alternative for stakeholders in the vitamin D testing landscape, to facilitate healthcare providers with a preferred technique in routine diagnostic laboratory practices.

View Report: https://www.transparencymarketresearch.com/vitamin-d-testing-market.html

25-hydroxy vitamin d measurement also serves as a less-invasive test in the vitamin D testing landscape. A recent study conducted by Trinity College, Dublin, and St. James Hospital, suggested the feasibility of the 25-hydroxy vitamin d test to measure the levels of vitamin D using only hair samples. Ongoing research & development in the vitamin D testing landscape warrant further validation of the 25-hydroxy vitamin d test to yield valuable information related to vitamin D physiology.

ELISA Technique Serves as Lucrative Alternative for Early Detection of VDD

Since the ELISA (Enzyme Linked Immunosorbent Assay) technique accounts for one of the largest market shares of ~ 28% in the vitamin D testing landscape, stakeholders are collaborating with research professionals to identify the association of serum 25-hydroxy vitamin D with leptin and visceral fat in type 2 diabetes patients suffering from osteoporosis. These research studies are being validated using the ELISA and ECL methods. As a result, the data establishes a strong association and reflected decreased 25-hydroxy vitamin D levels and increased leptin fat in type 2 diabetes patients suffering from osteoporosis.

Likewise, vitamin D deficiency (VDD) is a common health issue in women during the early stage of pregnancy. As such, various clinical trials using ELISA have been carried out to measure the concentrations of 25-hydroxy vitamin D. It has been proven that, women usually suffer from vitamin D deficiency during early pregnancy. Thus, stakeholders in the vitamin D testing landscape need to innovate and develop preventive techniques and ways of early detection of VDD during early pregnancy.

Request a Brochure of Heart Valve Devices Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=33557

Need to Harmonize Human Serum Treatment in Tandem with Vitamin D Antibodies

The accurate and precise measurement of 25-hydroxy vitamin D is one of the primary challenges that is associated with healthcare providers in the vitamin D testing landscape. As such, healthcare providers face limitations as vitamin D analytes are tightly bound to their serum transporter.

For example, liquid chromatography in relation to the mass spectrometry (LC-MS) technique offers an excellent level of accuracy and sensitivity in the vitamin D testing landscape. However, not all LC-MS results are deemed as equal by healthcare providers in hospitals and diagnostic laboratories. Likewise, radioimmunoassays (RIA) offer high specificity of 25-hydroxy vitamin D concentrations. Though, the reliability of the RIA technique is dependent on the quality of monoclonal antibody that is introduced during the test. Thus, harmonization of human serum treatment methods and narrowing the scope of vitamin D antibodies are critical steps that stakeholders and healthcare providers need to take in order to bring vitamin D testing methods to a universal agreement.

Analysts’ Viewpoint

Analysts of the vitamin D testing landscape have a positive outlook for market growth during the forecast period of 2019-2027. The vitamin D testing market is estimated to rise at a CAGR of ~6%. North America and Europe dominate the global market share in the vitamin D testing landscape, whereas, Asia Pacific has high growth potential in the coming years. One of the latest techniques in the vitamin D testing landscape is chemiluminescence immunoassays (CLIA). However, stakeholders and healthcare providers need to innovate on the interference problem that occurs in the LC-MS technique. Stakeholders must also address the cross-reaction limitation seen in vitamin D assays.

Vitamin D Deficiency and Testing

Vitamin D can be defined as a steroid vitamin, which is engaged in promoting metabolism and intestinal absorption of phosphorus and calcium. Vitamin D is produced in the skin, and is obtained through a diet. Under normal conditions of sun exposure, additional vitamin D supplements are not necessary. In order to determine if the vitamin D level in the serum plasma sample of an individual is low, vitamin D testing is performed, which measures the vitamin D levels in the body, accurately.

Significant Partnerships to Contribute to Market Growth

The global vitamin D testing market was valued at ~US$ 519 Mn in 2018, and is projected to reach ~US$ 877 Mn by 2027, expanding at a CAGR of ~6% from 2019 to 2027.
Significant distribution partnerships among market players for the distribution of their vitamin D test kits, globally, fuel the growth of the vitamin D testing market. For instance, NanoSpeed Diagnostics entered into an exclusive distribution partnership with Unilab Laboratories in 2015 for the distribution of Test4D, a 25-OH vitamin D deficiency test kit, in the Philippines. This enabled NanoSpeed to expand its presence in countries in Asia.
In 2016, Sekisui Diagnostics and Qualigen entered into a strategic partnership for the distribution of the FastPack IP System, which includes vitamin D, testosterone, TSH, free T4, PSA, and hCG.

Vitamin D Deficiency Epidemic

Vitamin D deficiency is an ignored epidemic that is highly prevalent, globally. However, no international organization or governmental body has declared a health emergency about the need of maintaining the required vitamin D levels in the blood. It is estimated that over 1 billion people around the world have vitamin D deficiency or insufficiency. Vitamin D deficiency primarily affects pregnant women, infants, neonates, children, and the elderly.
Vitamin D deficiency is known to be common in Northern Europe, especially in women with pigmented skin. The deficiency is reported to be three times more common in the winter months as compared to other months in the U.K.
Rise in the prevalence of vitamin D deficiency and the surging focus on its importance contribute to the increase in screening for vitamin D serum levels, which, in turn, boosts the growth of the global vitamin D testing market.

North America to Capture Leading Market Share

The report offers detailed segmentation of the global vitamin D testing market based on test, technique, patient type, indication, end-user, and region. In terms of test type, the global vitamin D testing market has been classified into 25-hydroxy D vitamin and 1,25-dihydroxy D vitamin.
Based on technique, the global vitamin D testing market has been categorized into radioimmunoassay, ELISA, HPLC, LC-MS, and others. In terms of patient type, the global vitamin D testing market has been bifurcated into adult and pediatric.
Based on indication, the global vitamin D testing market has been split into osteoporosis, rickets, thyroid disorders, malabsorption, vitamin D deficiency, and others. In terms of end-user, the global vitamin D testing market has been divided into hospitals, diagnostic laboratories, home care, point-of-care, and others.
Geographically, the global vitamin D testing market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America is projected to capture a leading share of the global vitamin D testing market during the period of forecast.

Key Companies in the Vitamin D Testing Market

The report provides profiles of the leading players operating in the global diagnostic imaging services market. These include

Bio-Rad Laboratories, Inc.
Abbott Laboratories
F. Hoffmann-La Roche AG
Thermo Fisher Scientific
DiaSys Diagnostic Systems GmbH
DiaSorin
bioMérieux
Siemens AG, Quest Diagnostics, and Danaher Corporation.